Science & Medical

Blue Buddha: The Synthetic Cannabinoid Blowing Peoples’ Heads Off

Blow Your Brains Out. This is the nickname of a new synthetic drug. Although users of all ages can consume Blue Buddha in all forms, it is mainly the younger generation using it in the form of an odorless and colorless liquid in electronic cigarettes. However, “The big difference with cannabis is that there are more overdoses, whether fatal or not,” explains one professor of addictology.

Blow Your Brains Out. This is the nickname of a new synthetic drug, also called PTC (“Pète ton crâne” in French) or Blue Buddha. This synthetic cannabinoid has become increasingly popular among young people in recent years. In early February, three French high school students from Sucy-en-Brie in the Val-de-Marne were hospitalized after vaping the drug.

Although users of all ages can consume Blue Buddha in all forms, it is mainly the younger generation using it in the form of an odorless and colorless liquid in electronic cigarettes.

What Is Blue Buddha

Blue Buddha contains no THC (or tetrahydrocannabinol), one of the molecules in cannabis causing psychotropic effects. However, it mimics its effects, producing a “zombie-like” effect, according to Laurent Karila, professor of addictology, a psychiatrist at the Paul Brousse hospital, and creator of the podcast Addiktion.

“The effects are quite similar to those of cannabis at first.” There is the sensation of appeasement, relaxation and anxiolytic effect, which then develop into hallucinations, to “an impression that what surrounds us is not real, that our body goes out of our body.”

Blue Buddha Causes Heart Attacks, Hallucinations, and Panic Attacks

Blue Buddha causes acute intoxications leading to hospitalizations more frequently than cannabis. “The big difference with cannabis is that there are more overdoses, whether fatal or not, as well as complications,” explains the professor.

They can first manifest as cardiac problems, with heart arrhythmias, tachycardia, or even a heart attack. PTC can also cause breathing difficulties, headaches, and lead to strokes. There are also psychiatric complications with the onset of depression, delusions, panic attacks, and even suicidal thoughts.

“It is much, much more dangerous for the health than cannabis, summarizes the psychiatrist. And in a young person who does not yet have a formed brain, the risk is even higher. If no death has so far been recorded in France following consuming Blue Buddha, in the United States, several people died after consuming it.

A Drug Not Detectable by the Usual Tests

Although illegal, Bue Buddha can be bought in a few clicks on the internet and costs only a few dozen euros, giving it an accessibility that’s all the more worrying. Moreover, the small vials of e-liquid and bags are “heavily marketed, very colorful, and have catchy names,” as explained by Laurent Karila.

As there is no THC in synthetic cannabinoids, the use of Blue Buddha is not detectable by the tests classically used to identify cannabis. “Young people are smart because they know better.” 

Synthetic cannabinoids like Blue Buddha “are coming under the microscope in France because of their increasing penetration into the territory,” explains the French Observatory of Drugs and Addictive Trends (OFDT). Nearly 4% of French youth under the age of 17 would have experimented at least once with a new synthetic drug, according to a study published in 2018.

(Featured image by Pawan Parihar via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in 20 Minutes, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Valerie Harrison

Valerie Harrison is a mom of two who likes reporting about the world of finance. She learned about the value of investing at a young age upon taking over her family's textile business when she was just a teenager. Valerie's passion for writing can be traced back to working with an editorial team at her corporate job, where she spent significant time working on market analysis and stock market predictions. Her portfolio includes real estate funds, government bonds, and equities in emerging markets such as cannabis, artificial intelligence, and cryptocurrencies.

Recent Posts

Women Represent 61% of Home Cannabis Growers in the U.S.

A survey found that women comprise 61% of home cannabis growers, marking a diversion from…

16 hours ago

Denmark Proposes Making Its Medical Cannabis Program Permanent

Denmark plans to make its pilot medical cannabis program permanent following its success in treating…

2 days ago

Polish Lawmakers Petition Donald Tusk for Cannabis Decriminalization

Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…

1 week ago

The UK Medical Cannabis Market: Growth, Diversification, and Opportunities

The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…

1 week ago

Alcohol & Cannabis: 60% of Cannabis Users Say It Helps Them Drink Less

A new study involving over 23,000 participants in New Zealand found that 60% of people…

1 week ago

French Interior and Justice Ministers Announce Measures to Combat Organized Crime

The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…

2 weeks ago